Open access

COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (9) - 30.11.2021

MandatorSwiss Federal Office of Public Health (FOPH)
Number of pages100
PublisherBern : Swiss School of Public Health plus (SSPH+)
  • COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report; 9
Publication date2021-11-30
First online date2021-11-30

This report focuses on the World Health Organization's (WHO) Emergency Use Listing (EUL) of authorized vaccines as of 26 November 2021. Bharat Biotech's new vaccine COVAXIN/ BBV152 received WHO EUL authorisation on 3 November 2021 leading to seven vaccines being now authorised for emergency use: BNT162b2/COMIRNATY (Pfizer-BioNTech, USA), Spikevax/Moderna COVID-19 Vaccine/ mRNA-1273 (Moderna, USA), Vaxzevria/ChAdOx1 nCoV-19/AZD1222/Covishield (AstraZeneca/Oxford, UK, India), Janssen Covid-19 vaccine/Johnson & Johnson (Janssen, USA), Sinopharm/BBIBP-CorV (China), Sinovac/CoronaVac (China), and COVAXIN/BBV152 (Bharat Biotech, India)]. This report provides a condensed summary concerning vaccine efficacy, safety, protection against variants, and further important information for each vaccine, in the form of a synoptic table. The information and data in this synoptic table was extracted from phase III clinical trials and observational studies. This report focuses on the latest data on vaccine effectiveness, vaccine induced immunity, breakthrough infections, and booster doses.

Citation (ISO format)
RODRIGUEZ VELÁSQUEZ, Sabina et al. COVID-19 vaccines in the WHO’s Emergency Use Listing (EUL) Report (9) - 30.11.2021. 2021
Main files (1)
  • PID : unige:157781

Technical informations

Creation01/07/2022 3:35:00 PM
First validation01/07/2022 3:35:00 PM
Update time03/16/2023 2:18:51 AM
Status update03/16/2023 2:18:50 AM
Last indexation01/29/2024 11:15:07 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack